INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 3 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2 | 0.0% | 3,815 | -4.7% | 0.00% | -50.0% |
| Q3 2023 | $2 | 0.0% | 4,002 | -7.1% | 0.00% | 0.0% |
| Q2 2023 | $2 | -33.3% | 4,306 | +6.2% | 0.00% | -33.3% |
| Q1 2023 | $3 | -81.2% | 4,053 | -58.1% | 0.00% | -57.1% |
| Q4 2022 | $16 | -99.8% | 9,680 | +92.7% | 0.01% | -12.5% |
| Q3 2022 | $9,000 | 0.0% | 5,024 | -0.1% | 0.01% | +14.3% |
| Q2 2022 | $9,000 | -60.9% | 5,028 | -23.0% | 0.01% | -53.3% |
| Q1 2022 | $23,000 | -45.2% | 6,528 | -21.8% | 0.02% | -74.6% |
| Q4 2021 | $42,000 | – | 8,347 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STONERIDGE INVESTMENT PARTNERS LLC | 521,775 | $4,258,000 | 0.53% |
| Round Table Services, LLC | 73,500 | $600,000 | 0.47% |
| Cheyne Capital Management (UK) LLP | 160,000 | $1,305,000 | 0.42% |
| SABBY MANAGEMENT, LLC | 906,000 | $7,393,000 | 0.27% |
| Bellevue Asset Management AG | 200,000 | $1,632,000 | 0.23% |
| GLOBEFLEX CAPITAL L P | 122,000 | $996,000 | 0.18% |
| WASATCH ADVISORS LP | 1,959,114 | $15,986,000 | 0.17% |
| EMERALD ADVISERS, LLC | 288,486 | $2,354,000 | 0.11% |
| Rotella Capital Management, Inc. | 13,840 | $113,000 | 0.09% |
| Catalyst Capital Advisors LLC | 65,000 | $530,000 | 0.06% |